DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE: 127 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
127
Total FAERS Reports
6 (4.7%)
Deaths Reported
14
Hospitalizations
127
As Primary/Secondary Suspect
4
Life-Threatening
3
Disabilities
Active Ingredient: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE ·
First Report: 20180101 · Latest Report: 20241103
What Are the Most Common DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE Side Effects?
#1 Most Reported
Drug ineffective
48 reports (37.8%)
#2 Most Reported
Product substitution issue
23 reports (18.1%)
#3 Most Reported
Headache
17 reports (13.4%)
All DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 48 | 37.8% | 0 | 0 |
| Product substitution issue | 23 | 18.1% | 0 | 0 |
| Headache | 17 | 13.4% | 0 | 1 |
| Nausea | 16 | 12.6% | 0 | 1 |
| Drug screen positive | 11 | 8.7% | 4 | 2 |
| Feeling abnormal | 11 | 8.7% | 0 | 0 |
| Brain fog | 10 | 7.9% | 0 | 0 |
| Therapeutic response changed | 10 | 7.9% | 0 | 0 |
| Anxiety | 9 | 7.1% | 0 | 0 |
| Fatigue | 9 | 7.1% | 0 | 0 |
| Loss of personal independence in daily activities | 9 | 7.1% | 0 | 0 |
| Product quality issue | 9 | 7.1% | 0 | 0 |
| Irritability | 8 | 6.3% | 0 | 0 |
| Depression | 7 | 5.5% | 0 | 0 |
| Agitation | 6 | 4.7% | 0 | 2 |
| Disturbance in attention | 6 | 4.7% | 0 | 0 |
| Dizziness | 6 | 4.7% | 0 | 1 |
| Drug abuse | 6 | 4.7% | 1 | 3 |
| Inability to afford medication | 6 | 4.7% | 0 | 0 |
| Pain | 6 | 4.7% | 1 | 1 |
Who Reports DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE Side Effects? Age & Gender Data
Gender: 46.3% female, 53.7% male. Average age: 40.6 years. Most reports from: US. View detailed demographics →
Is DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 2 | 0 | 0 |
| 2021 | 2 | 0 | 2 |
| 2023 | 7 | 0 | 0 |
| 2024 | 20 | 0 | 2 |
What Is DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 69 |
| Attention deficit hyperactivity disorder | 47 |
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs Alternatives: Which Is Safer?
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROMETHORPHAN
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\GUAIFENESIN\PHENYLEPHRINE
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROMETHORPHAN HYDROBROMIDE\QUINIDINE
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROMETHORPHAN\GUAIFENESIN
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROSE
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROSE\DEXTROSE
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROSE\DEXTROSE\DOBUTAMINE\DOBUTAMINE
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE vs DEXTROSE\HEPARIN
Official FDA Label for DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE AND AMPHETAMINE
Official prescribing information from the FDA-approved drug label.